- Large target markets with real human impact (26,000 pediatric and 800,000 adult OR and ICU patients annually).
- Billion dollar addressable market (adult and pediatric pumps), and additional estimated healthcare cost reductions of $500M annually.
- Strong consumables-based business model.
- 5 issued patents, more IP in development.
- Clear FDA 510(k) clearance pathway—expected 2 years after current round of seed funding.
- Seeking additional funding to complete pediatric pump development through 510(k) clearance to market launch.